HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Effect of traxanox sodium on SRS-A release in bronchial and peritoneal anaphylaxis].

Abstract
The effect of traxanox on SRS-A release was examined in vivo and compared with that of disodium cromoglycate (DSCG). Intravenous antigen challenge produced an intense anaphylactic bronchoconstriction that showed a peak time of 5 min in egg albumin-sensitized guinea pigs pretreated with three agents, mepyramine (2.5 mg/kg, i.v.), indomethacin (1 mg/kg, i.v.) and propranolol (0.05 mg/kg, i.v.). This bronchoconstriction was almost completely inhibited by additional pretreatment with an SRS-A antagonist, FPL 55712 (2.5 mg/kg, i.v.). A lipoxygenase inhibitor, BW755C (10 mg/kg, i.v.), also significantly inhibited this reaction. These results indicate that this anaphylactic bronchoconstriction is due to the release of endogenous SRS-A. In this model, traxanox (5 and 10 mg/kg, i.v.) showed a dose-related inhibition, but DSCG (10 mg/kg, i.v.) did not. FPL 55712 (1 mg/kg, i.v.) administered at the peak time of the bronchoconstriction caused a relaxation. Traxanox, on the other hand, failed to relax this reaction. In IgE-mediated rat passive peritoneal anaphylaxis (PPA), traxanox (0.01--10 micrograms/rat, i.p.) inhibited the release of SRS-A and histamine dose-dependently. This inhibitory effect was about 10--20 times as potent as that of DSCG. In addition, both traxanox (0.1 microgram/rat, i.p.) and DSCG (1 microgram/rat, i.p.) showed a synergistic effect in combination with isoproterenol (0.01 microgram/rat, i.p.) and an additive effect with theophylline (100 micrograms/rat, i.p.) in inhibiting the release of SRS-A in rat PPA. These results suggest that traxanox inhibits the release of SRS-A in vivo, so that it may be clinically effective in treating patients with allergic bronchial asthma.
AuthorsM Terasawa, T Imayoshi, K Goto
JournalNihon yakurigaku zasshi. Folia pharmacologica Japonica (Nihon Yakurigaku Zasshi) Vol. 82 Issue 1 Pg. 93-101 (Jul 1983) ISSN: 0015-5691 [Print] Japan
PMID6194083 (Publication Type: Journal Article)
Chemical References
  • Chromones
  • Histamine H1 Antagonists
  • SRS-A
  • Propranolol
  • traxanox
  • Pyrilamine
  • Isoproterenol
  • Cromolyn Sodium
Topics
  • Anaphylaxis (metabolism)
  • Animals
  • Bronchi (drug effects, metabolism)
  • Chromones (pharmacology)
  • Cromolyn Sodium (pharmacology)
  • Female
  • Guinea Pigs
  • Histamine H1 Antagonists (pharmacology)
  • Histamine Release (drug effects)
  • Isoproterenol (pharmacology)
  • Male
  • Muscle Contraction (drug effects)
  • Peritoneal Cavity
  • Propranolol (pharmacology)
  • Pyrilamine (pharmacology)
  • Rats
  • Rats, Inbred Strains
  • SRS-A (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: